The pharmacology behind the tapering planner, written out so you can check the reasoning rather than take the schedule on trust. Organised by drug, with the source for each figure.
What the knowledge base covers
Half-life and active metabolites per agent
Receptor occupancy curves and why they make taper steps non-linear
Discontinuation symptom risk by drug
Available formulations and the smallest reduction each one allows
Source guidelines behind each recommendation
For clinical decision support only. Not a substitute for professional judgment.